{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:13:18Z","timestamp":1793686398782,"version":"4.5.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00134-023-07266-7","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:02:26Z","timestamp":1702980146000},"page":"17-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Diagnosis and management of autoimmune diseases in the ICU"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-7195","authenticated-orcid":false,"given":"Guillaume","family":"Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen M.","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Ranzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"7266_CR1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/d41586-021-01833-y","volume":"595","author":"R Hodson","year":"2021","unstructured":"Hodson R (2021) Autoimmune disease. Nature 595:S45\u2013S45. https:\/\/doi.org\/10.1038\/d41586-021-01833-y","journal-title":"Nature"},{"key":"7266_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.autrev.2012.06.002","volume":"12","author":"OL Quintero","year":"2013","unstructured":"Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12:380\u2013395. https:\/\/doi.org\/10.1016\/j.autrev.2012.06.002","journal-title":"Autoimmun Rev"},{"key":"7266_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/0961203320941941","volume":"29","author":"A Su\u00e1rez-Avellaneda","year":"2020","unstructured":"Su\u00e1rez-Avellaneda A, Quintana JH, Arag\u00f3n CC et al (2020) Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus 29:1364\u20131376. https:\/\/doi.org\/10.1177\/0961203320941941","journal-title":"Lupus"},{"key":"7266_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/s0749-0704(02)00025-8","volume":"18","author":"NM Janssen","year":"2002","unstructured":"Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729\u2013748. https:\/\/doi.org\/10.1016\/s0749-0704(02)00025-8","journal-title":"Crit Care Clin"},{"key":"7266_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.chest.2020.03.050","volume":"158","author":"R Larcher","year":"2020","unstructured":"Larcher R, de Chambrun MP, Garnier F et al (2020) One-year outcome of critically Ill patients with systemic rheumatic disease: a multicenter cohort study. Chest 158:1017\u20131026. https:\/\/doi.org\/10.1016\/j.chest.2020.03.050","journal-title":"Chest"},{"key":"7266_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1378\/chest.14-3098","volume":"148","author":"G Dumas","year":"2015","unstructured":"Dumas G, Geri G, Montlahuc C et al (2015) Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest 148:927\u2013935. https:\/\/doi.org\/10.1378\/chest.14-3098","journal-title":"Chest"},{"key":"7266_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/RHU.0000000000000827","volume":"25","author":"J Naranjo-Escobar","year":"2019","unstructured":"Naranjo-Escobar J, Hormaza AA, Posso-Osorio I et al (2019) Systemic sclerosis at an intensive care unit: a case series and literature review. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 25:181\u2013185. https:\/\/doi.org\/10.1097\/RHU.0000000000000827","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"7266_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrneph.2016.124","volume":"12","author":"TG Woodworth","year":"2016","unstructured":"Woodworth TG, Suliman YA, Li W et al (2016) Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol 12:678\u2013691. https:\/\/doi.org\/10.1038\/nrneph.2016.124","journal-title":"Nat Rev Nephrol"},{"key":"7266_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3899\/jrheum.131210","volume":"41","author":"L Mouthon","year":"2014","unstructured":"Mouthon L, Bussone G, Berezn\u00e9 A et al (2014) Scleroderma renal crisis. J Rheumatol 41:1040\u20131048. https:\/\/doi.org\/10.3899\/jrheum.131210","journal-title":"J Rheumatol"},{"key":"7266_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3899\/jrheum.171186","volume":"46","author":"SM Gordon","year":"2019","unstructured":"Gordon SM, Stitt RS, Nee R et al (2019) Risk factors for future scleroderma renal crisis at systemic sclerosis diagnosis. J Rheumatol 46:85\u201392. https:\/\/doi.org\/10.3899\/jrheum.171186","journal-title":"J Rheumatol"},{"key":"7266_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/0003319711432861","volume":"63","author":"M Mohokum","year":"2012","unstructured":"Mohokum M, Hartmann P, Schlattmann P (2012) The association of Raynaud syndrome with \u03b2-blockers: a meta-analysis. Angiology 63:535\u2013540. https:\/\/doi.org\/10.1177\/0003319711432861","journal-title":"Angiology"},{"key":"7266_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103162","volume":"21","author":"C Vigneron","year":"2022","unstructured":"Vigneron C, P\u00e8ne F, Charpentier J et al (2022) Scleroderma cardiac crisis: a-life-threatening but reversible complication of systemic sclerosis. Autoimmun Rev 21:103162. https:\/\/doi.org\/10.1016\/j.autrev.2022.103162","journal-title":"Autoimmun Rev"},{"key":"7266_CR13","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0208-2022","author":"N Boyle","year":"2022","unstructured":"Boyle N, O\u2019Callaghan M, Ataya A et al (2022) Pulmonary renal syndrome: a clinical review. Breathe. https:\/\/doi.org\/10.1183\/20734735.0208-2022","journal-title":"Breathe"},{"key":"7266_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13054-020-02936-0","volume":"24","author":"A Mirouse","year":"2020","unstructured":"Mirouse A, Parrot A, Audigier V et al (2020) Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Crit Care Lond Engl 24:231. https:\/\/doi.org\/10.1186\/s13054-020-02936-0","journal-title":"Crit Care Lond Engl"},{"key":"7266_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/art.39562","volume":"68","author":"R Cartin-Ceba","year":"2016","unstructured":"Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO et al (2016) Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol Hoboken NJ 68:1467\u20131476. https:\/\/doi.org\/10.1002\/art.39562","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"7266_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.rmed.2011.05.012","volume":"105","author":"C McCabe","year":"2011","unstructured":"McCabe C, Jones Q, Nikolopoulou A et al (2011) Pulmonary-renal syndromes: an update for respiratory physicians. Respir Med 105:1413\u20131421. https:\/\/doi.org\/10.1016\/j.rmed.2011.05.012","journal-title":"Respir Med"},{"key":"7266_CR17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018","author":"V Cottin","year":"2018","unstructured":"Cottin V, Hirani NA, Hotchkin DL et al (2018) Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0076-2018","journal-title":"Eur Respir Rev"},{"key":"7266_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","volume":"8","author":"C Vuillard","year":"2018","unstructured":"Vuillard C, de Chambrun M, de Prost N et al (2018) Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-{MDA}-5 dermato-pulmonary syndrome: a French multicenter retrospective study. Ann Intens Care 8:87. https:\/\/doi.org\/10.1186\/s13613-018-0433-3","journal-title":"Ann Intens Care"},{"key":"7266_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104897","volume":"9","author":"L Zafrani","year":"2014","unstructured":"Zafrani L, Lemiale V, Lapidus N et al (2014) Acute respiratory failure in critically ill patients with interstitial lung disease. PLoS One 9:e104897. https:\/\/doi.org\/10.1371\/journal.pone.0104897","journal-title":"PLoS One"},{"key":"7266_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3899\/jrheum.141617","volume":"42","author":"F P\u00e8ne","year":"2015","unstructured":"P\u00e8ne F, Hissem T, B\u00e9rezn\u00e9 A et al (2015) Outcome of patients with systemic sclerosis in the intensive care unit. J Rheumatol 42:1406\u20131412. https:\/\/doi.org\/10.3899\/jrheum.141617","journal-title":"J Rheumatol"},{"key":"7266_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1378\/chest.12-0741","volume":"143","author":"R Vij","year":"2013","unstructured":"Vij R, Strek ME (2013) Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 143:814\u2013824. https:\/\/doi.org\/10.1378\/chest.12-0741","journal-title":"Chest"},{"key":"7266_CR22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.athoracsur.2018.04.068","volume":"106","author":"S Chicotka","year":"2018","unstructured":"Chicotka S, Pedroso FE, Agerstrand CL et al (2018) Increasing opportunity for lung transplant in interstitial lung disease with pulmonary hypertension. Ann Thorac Surg 106:1812\u20131819. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.04.068","journal-title":"Ann Thorac Surg"},{"key":"7266_CR23","first-page":"825","volume":"30","author":"C Wanitpongpun","year":"2012","unstructured":"Wanitpongpun C, Teawtrakul N, Mahakkanukrauh A et al (2012) Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. Clin Exp Rheumatol 30:825\u2013829","journal-title":"Clin Exp Rheumatol"},{"key":"7266_CR24","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-010-1936-z","volume":"36","author":"S Buyse","year":"2010","unstructured":"Buyse S, Teixeira L, Galicier L et al (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intens Care Med 36:1695\u20131702. https:\/\/doi.org\/10.1007\/s00134-010-1936-z","journal-title":"Intens Care Med"},{"key":"7266_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00134-008-1111-y","volume":"34","author":"C Cr\u00e9put","year":"2008","unstructured":"Cr\u00e9put C, Galicier L, Buyse S, Azoulay E (2008) Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intens Care Med 34:1177\u20131187. https:\/\/doi.org\/10.1007\/s00134-008-1111-y","journal-title":"Intens Care Med"},{"key":"7266_CR26","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O et al (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthr Rheumatol Hoboken NJ 66:2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthr Rheumatol Hoboken NJ"},{"key":"7266_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002318","volume":"94","author":"T Barba","year":"2015","unstructured":"Barba T, Maucort-Boulch D, Iwaz J et al (2015) Hemophagocytic lymphohistiocytosis in intensive care unit: A 71-case strobe-compliant retrospective study. Medicine (Baltimore) 94:e2318. https:\/\/doi.org\/10.1097\/MD.0000000000002318","journal-title":"Medicine (Baltimore)"},{"key":"7266_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"7266_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.06.003","volume":"103","author":"M Pineton de Chambrun","year":"2019","unstructured":"Pineton de Chambrun M, Larcher R, P\u00e8ne F et al (2019) CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. J Autoimmun 103:102292. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.003","journal-title":"J Autoimmun"},{"key":"7266_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13613-021-00946-x","volume":"11","author":"A Gibelin","year":"2021","unstructured":"Gibelin A, Dumas G, Valade S et al (2021) Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study. Ann Intens Care 11:158. https:\/\/doi.org\/10.1186\/s13613-021-00946-x","journal-title":"Ann Intens Care"},{"key":"7266_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13054-016-1189-5","volume":"20","author":"A Kimmoun","year":"2016","unstructured":"Kimmoun A, Baux E, Das V et al (2016) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care Lond Engl 20:27. https:\/\/doi.org\/10.1186\/s13054-016-1189-5","journal-title":"Crit Care Lond Engl"},{"key":"7266_CR32","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.chest.2019.11.010","volume":"157","author":"M Pineton de Chambrun","year":"2020","unstructured":"Pineton de Chambrun M, Larcher R, P\u00e8ne F et al (2020) In-Hospital mortality-associated factors in patients with thrombotic antiphospholipid syndrome requiring ICU admission. Chest 157:1158\u20131166. https:\/\/doi.org\/10.1016\/j.chest.2019.11.010","journal-title":"Chest"},{"key":"7266_CR33","doi-asserted-by":"publisher","first-page":"E371","DOI":"10.1002\/ajh.26665","volume":"97","author":"C Pouchelon","year":"2022","unstructured":"Pouchelon C, Lafont C, Lafarge A et al (2022) Characteristics and outcome of adults with severe autoimmune hemolytic anemia admitted to the intensive care unit: Results from a large French observational study. Am J Hematol 97:E371\u2013E373. https:\/\/doi.org\/10.1002\/ajh.26665","journal-title":"Am J Hematol"},{"key":"7266_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13075-018-1776-8","volume":"20","author":"J Narv\u00e1ez","year":"2018","unstructured":"Narv\u00e1ez J, Borrell H, S\u00e1nchez-Alonso F et al (2018) Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthr Res Ther 20:280. https:\/\/doi.org\/10.1186\/s13075-018-1776-8","journal-title":"Arthr Res Ther"},{"key":"7266_CR35","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.autrev.2016.07.021","volume":"15","author":"L Duron","year":"2016","unstructured":"Duron L, Cohen-Aubart F, Diot E et al (2016) Shrinking lung syndrome associated with systemic lupus erythematosus: a multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes. Autoimmun Rev 15:994\u20131000. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.021","journal-title":"Autoimmun Rev"},{"key":"7266_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK (2016) Management of interstitial lung disease associated with connective tissue disease. The BMJ 352:h6819. https:\/\/doi.org\/10.1136\/bmj.h6819","journal-title":"The BMJ"},{"key":"7266_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1741-7015-11-95","volume":"11","author":"A Kronbichler","year":"2013","unstructured":"Kronbichler A, Mayer G (2013) Renal involvement in autoimmune connective tissue diseases. BMC Med 11:95. https:\/\/doi.org\/10.1186\/1741-7015-11-95","journal-title":"BMC Med"},{"key":"7266_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13613-017-0262-9","volume":"7","author":"J Demiselle","year":"2017","unstructured":"Demiselle J, Auchabie J, Beloncle F et al (2017) Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intens Care 7:39. https:\/\/doi.org\/10.1186\/s13613-017-0262-9","journal-title":"Ann Intens Care"},{"key":"7266_CR39","unstructured":"Lee BY, Lee SM, Song JS, Song JW (2014) Clinical course and outcome of vasculitis related interstitial lung disease. Eur Respir J 44:"},{"key":"7266_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/cc2937","volume":"9","author":"D Semple","year":"2005","unstructured":"Semple D, Keogh J, Forni L, Venn R (2005) Clinical review: Vasculitis on the intensive care unit \u2013 part 2: treatment and prognosis. Crit Care Lond Engl 9:193\u2013197. https:\/\/doi.org\/10.1186\/cc2937","journal-title":"Crit Care Lond Engl"},{"key":"7266_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00134-022-06967-9","volume":"49","author":"A Gaillet","year":"2023","unstructured":"Gaillet A, Bay P, P\u00e9ju E et al (2023) Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit. Intens Care Med 49:291\u2013301. https:\/\/doi.org\/10.1007\/s00134-022-06967-9","journal-title":"Intens Care Med"},{"key":"7266_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40620-016-0303-8","volume":"29","author":"F Maritati","year":"2016","unstructured":"Maritati F, Iannuzzella F, Pavia MP et al (2016) Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 29:495\u2013505. https:\/\/doi.org\/10.1007\/s40620-016-0303-8","journal-title":"J Nephrol"},{"key":"7266_CR43","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells10040766","volume":"10","author":"P S\u00e8ve","year":"2021","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F et al (2021) Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells 10:766. https:\/\/doi.org\/10.3390\/cells10040766","journal-title":"Cells"},{"key":"7266_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","volume":"16","author":"X Bossuyt","year":"2020","unstructured":"Bossuyt X, De Langhe E, Borghi MO, Meroni PL (2020) Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol 16:715\u2013726. https:\/\/doi.org\/10.1038\/s41584-020-00522-w","journal-title":"Nat Rev Rheumatol"},{"key":"7266_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","author":"B Hellmich","year":"2023","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"7266_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A, Kostopoulou M, Cheema K et al (2020) 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA\u2013EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79:713\u2013723. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216924","journal-title":"Ann Rheum Dis"},{"key":"7266_CR47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2019.PA1946","author":"G Okumus","year":"2019","unstructured":"Okumus G, Bingol Z, Sarisoy M et al (2019) The role of salivary gland biopsy in the diagnosis of sarcoidosis. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.congress-2019.PA1946","journal-title":"Eur Respir J"},{"key":"7266_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejim.2022.02.006","volume":"98","author":"Y Kouchit","year":"2022","unstructured":"Kouchit Y, Morand L, Martis N (2022) Mortality and its risk factors in critically ill patients with connective tissue diseases: a meta-analysis. Eur J Intern Med 98:83\u201392. https:\/\/doi.org\/10.1016\/j.ejim.2022.02.006","journal-title":"Eur J Intern Med"},{"key":"7266_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11739-022-03154-y","volume":"18","author":"M Covino","year":"2023","unstructured":"Covino M, Gallo A, Simeoni B et al (2023) Procalcitonin for the early discrimination of fever etiology in patients with systemic autoimmune diseases attending the emergency department. Intern Emerg Med 18:617\u2013625. https:\/\/doi.org\/10.1007\/s11739-022-03154-y","journal-title":"Intern Emerg Med"},{"key":"7266_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R et al (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19\u201327. https:\/\/doi.org\/10.1097\/MD.0b013e318205a4c6","journal-title":"Medicine (Baltimore)"},{"key":"7266_CR51","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh C-A et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382:622\u2013631. https:\/\/doi.org\/10.1056\/NEJMoa1803537","journal-title":"N Engl J Med"},{"key":"7266_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.berh.2013.01.002","volume":"27","author":"EM Wilfong","year":"2013","unstructured":"Wilfong EM, Seo P (2013) Vasculitis in the intensive care unit. Best Pract Res Clin Rheumatol 27:95\u2013106. https:\/\/doi.org\/10.1016\/j.berh.2013.01.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7266_CR53","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","volume":"59","author":"G Ruiz-Irastorza","year":"2020","unstructured":"Ruiz-Irastorza G, Bertsias G (2020) Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatol Oxf Engl 59:v69\u2013v81. https:\/\/doi.org\/10.1093\/rheumatology\/keaa403","journal-title":"Rheumatol Oxf Engl"},{"key":"7266_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2018-213846","volume":"78","author":"I Uthman","year":"2019","unstructured":"Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M (2019) Management of antiphospholipid syndrome. Ann Rheum Dis 78:155\u2013161. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213846","journal-title":"Ann Rheum Dis"},{"key":"7266_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.05.007","volume":"92","author":"R Cervera","year":"2018","unstructured":"Cervera R, Rodr\u00edguez-Pint\u00f3 I, Espinosa G (2018) The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun 92:1\u201311. https:\/\/doi.org\/10.1016\/j.jaut.2018.05.007","journal-title":"J Autoimmun"},{"key":"7266_CR56","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","volume":"46","author":"E Azoulay","year":"2020","unstructured":"Azoulay E, Russell L, Van de Louw A et al (2020) Diagnosis of severe respiratory infections in immunocompromised patients. Intens Care Med 46:298\u2013314. https:\/\/doi.org\/10.1007\/s00134-019-05906-5","journal-title":"Intens Care Med"},{"key":"7266_CR57","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/rheumatology\/kez575","volume":"59","author":"A Lafarge","year":"2020","unstructured":"Lafarge A, Joseph A, Pagnoux C et al (2020) Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. Rheumatol Oxf Engl 59:2250\u20132257. https:\/\/doi.org\/10.1093\/rheumatology\/kez575","journal-title":"Rheumatol Oxf Engl"},{"key":"7266_CR58","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P et al (2009) Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthr Rheum 60:1884\u20131894. https:\/\/doi.org\/10.1002\/art.24632","journal-title":"Arthr Rheum"},{"key":"7266_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M et al (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82:742\u2013753. https:\/\/doi.org\/10.1136\/ard-2022-223335","journal-title":"Ann Rheum Dis"},{"key":"7266_CR60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1182\/hematology.2020000171","volume":"2020","author":"ER Engel","year":"2020","unstructured":"Engel ER, Walter JE (2020) Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs. Hematology 2020:312\u2013318. https:\/\/doi.org\/10.1182\/hematology.2020000171","journal-title":"Hematology"},{"key":"7266_CR61","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s10067-021-05660-4","volume":"40","author":"H-C Hsu","year":"2021","unstructured":"Hsu H-C, Chang Y-S, Hou T-Y et al (2021) Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study. Clin Rheumatol 40:3755\u20133763. https:\/\/doi.org\/10.1007\/s10067-021-05660-4","journal-title":"Clin Rheumatol"},{"key":"7266_CR62","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.39670","volume":"68","author":"H Yun","year":"2016","unstructured":"Yun H, Yang S, Chen L et al (2016) Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. Arthr Rheumatol Hoboken NJ 68:2328\u20132337. https:\/\/doi.org\/10.1002\/art.39670","journal-title":"Arthr Rheumatol Hoboken NJ"},{"key":"7266_CR63","doi-asserted-by":"publisher","unstructured":"Conners EE (2023) Screening and testing for Hepatitis B virus infection: CDC recommendations \u2014 United States, 2023. MMWR Recomm Rep https:\/\/doi.org\/10.15585\/mmwr.rr7201a1","DOI":"10.15585\/mmwr.rr7201a1"},{"key":"7266_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2334-13-78","volume":"13","author":"D Buonfrate","year":"2013","unstructured":"Buonfrate D, Requena-Mendez A, Angheben A et al (2013) Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13:78. https:\/\/doi.org\/10.1186\/1471-2334-13-78","journal-title":"BMC Infect Dis"},{"key":"7266_CR65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s15010-015-0799-1","volume":"43","author":"G Geri","year":"2015","unstructured":"Geri G, Rabbat A, Mayaux J et al (2015) Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature. Infection 43:691\u2013698. https:\/\/doi.org\/10.1007\/s15010-015-0799-1","journal-title":"Infection"},{"key":"7266_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13618","volume":"33","author":"RM La Hoz","year":"2019","unstructured":"La Hoz RM, Morris MI, AST Infectious Diseases Community of Practice (2019) Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13618. https:\/\/doi.org\/10.1111\/ctr.13618","journal-title":"Clin Transplant"},{"key":"7266_CR67","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4269\/ajtmh.16-0923","volume":"97","author":"A Requena-M\u00e9ndez","year":"2017","unstructured":"Requena-M\u00e9ndez A, Buonfrate D, Gomez-Junyent J et al (2017) Evidence-based guidelines for screening and management of strongyloidiasis in Non-Endemic Countries. Am J Trop Med Hyg 97:645\u2013652. https:\/\/doi.org\/10.4269\/ajtmh.16-0923","journal-title":"Am J Trop Med Hyg"},{"key":"7266_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac133","author":"K Takabayashi","year":"2022","unstructured":"Takabayashi K, Ando F, Ikeda K et al (2022) Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study. Mod Rheumatol. https:\/\/doi.org\/10.1093\/mr\/roac133","journal-title":"Mod Rheumatol"},{"key":"7266_CR69","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/hematology.2020000116","volume":"2020","author":"L Malpica","year":"2020","unstructured":"Malpica L, Moll S (2020) Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases. Hematology 2020:319\u2013327. https:\/\/doi.org\/10.1182\/hematology.2020000116","journal-title":"Hematology"},{"issue":"Supp 3","key":"7266_CR70","doi-asserted-by":"publisher","first-page":"iii2","DOI":"10.1136\/jnnp.74.suppl_3.iii2","volume":"74","author":"RS Howard","year":"2003","unstructured":"Howard RS, Kullmann DM, Hirsch NP (2003) Admission to neurological intensive care: who, when, and why? J Neurol Neurosurg Psychiatry 74(Supp 3):iii2\u2013iii9. https:\/\/doi.org\/10.1136\/jnnp.74.suppl_3.iii2","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7266_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577953","volume":"371","author":"G Beecher","year":"2022","unstructured":"Beecher G, Howe BM, Shelly S et al (2022) Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN. J Neuroimmunol 371:577953. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577953","journal-title":"J Neuroimmunol"},{"key":"7266_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11940-020-00631-7","volume":"22","author":"A Dworetz","year":"2020","unstructured":"Dworetz A, Graley C, Padia H, Gwathmey KG (2020) Neurologic manifestations of systemic disease: peripheral nervous system. Curr Treat Options Neurol 22:25. https:\/\/doi.org\/10.1007\/s11940-020-00631-7","journal-title":"Curr Treat Options Neurol"},{"key":"7266_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11940-020-00636-2","volume":"22","author":"DA Lapides","year":"2020","unstructured":"Lapides DA, McDonald MM (2020) Inflammatory manifestations of systemic diseases in the central nervous system. Curr Treat Options Neurol 22:26. https:\/\/doi.org\/10.1007\/s11940-020-00636-2","journal-title":"Curr Treat Options Neurol"},{"key":"7266_CR74","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00134-019-05773-0","volume":"45","author":"R Sonneville","year":"2019","unstructured":"Sonneville R, Venkatesan A, Honnorat J (2019) Understanding auto-immune encephalitis in the ICU. Intensive Care Med 45:1795\u20131798. https:\/\/doi.org\/10.1007\/s00134-019-05773-0","journal-title":"Intensive Care Med"},{"key":"7266_CR75","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","volume":"48","author":"PR Bauer","year":"2022","unstructured":"Bauer PR, Ostermann M, Russell L et al (2022) Plasma exchange in the intensive care unit: a narrative review. Intens Care Med 48:1382\u20131396. https:\/\/doi.org\/10.1007\/s00134-022-06793-z","journal-title":"Intens Care Med"},{"key":"7266_CR76","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","volume":"21","author":"H Pr\u00fcss","year":"2021","unstructured":"Pr\u00fcss H (2021) Autoantibodies in neurological disease. Nat Rev Immunol 21:798\u2013813. https:\/\/doi.org\/10.1038\/s41577-021-00543-w","journal-title":"Nat Rev Immunol"},{"key":"7266_CR77","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehv479","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P (2015) The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 36:2873\u20132874. https:\/\/doi.org\/10.1093\/eurheartj\/ehv479","journal-title":"Eur Heart J"},{"key":"7266_CR78","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/heartjnl-2019-316460","volume":"107","author":"G Sen","year":"2021","unstructured":"Sen G, Gordon P, Sado DM (2021) Cardiac manifestations of rheumatological disease: a synopsis for the cardiologist. Heart 107:1173\u20131181. https:\/\/doi.org\/10.1136\/heartjnl-2019-316460","journal-title":"Heart"},{"key":"7266_CR79","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01913-2018","journal-title":"Eur Respir J"},{"key":"7266_CR80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","volume":"91","author":"G Geri","year":"2012","unstructured":"Geri G, Wechsler B, Thi Huong DL et al (2012) Spectrum of cardiac lesions in Beh\u00e7et disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91:25. https:\/\/doi.org\/10.1097\/MD.0b013e3182428f49","journal-title":"Medicine (Baltimore)"},{"key":"7266_CR81","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G et al (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. The Lancet 400:733\u2013743. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6","journal-title":"The Lancet"},{"key":"7266_CR82","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.ejim.2012.11.018","volume":"24","author":"S Faguer","year":"2013","unstructured":"Faguer S, Ciroldi M, Mariotte E et al (2013) Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med 24:e40\u2013e44. https:\/\/doi.org\/10.1016\/j.ejim.2012.11.018","journal-title":"Eur J Intern Med"},{"key":"7266_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13613-017-0281-6","volume":"7","author":"N de Prost","year":"2017","unstructured":"de Prost N, Pham T, Carteaux G et al (2017) Etiologies, diagnostic work-up and outcomes of acute respiratory distress syndrome with no common risk factor: a prospective multicenter study. Ann Intens Care 7:69. https:\/\/doi.org\/10.1186\/s13613-017-0281-6","journal-title":"Ann Intens Care"},{"key":"7266_CR84","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00134-015-4064-y","volume":"42","author":"A Gibelin","year":"2016","unstructured":"Gibelin A, Parrot A, Maitre B et al (2016) Acute respiratory distress syndrome mimickers lacking common risk factors of the Berlin definition. Intens Care Med 42:164\u2013172. https:\/\/doi.org\/10.1007\/s00134-015-4064-y","journal-title":"Intens Care Med"},{"key":"7266_CR85","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00134-017-4799-8","volume":"43","author":"M Darmon","year":"2017","unstructured":"Darmon M, Ostermann M, Cerda J et al (2017) Diagnostic work-up and specific causes of acute kidney injury. Intens Care Med 43:829\u2013840. https:\/\/doi.org\/10.1007\/s00134-017-4799-8","journal-title":"Intens Care Med"},{"key":"7266_CR86","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00134-012-2796-5","volume":"39","author":"S Nisula","year":"2013","unstructured":"Nisula S, Kaukonen K-M, Vaara ST et al (2013) Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intens Care Med 39:420\u2013428. https:\/\/doi.org\/10.1007\/s00134-012-2796-5","journal-title":"Intens Care Med"},{"key":"7266_CR87","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1007\/s00134-012-2634-9","volume":"38","author":"J-F Augusto","year":"2012","unstructured":"Augusto J-F, Lassalle V, Fillatre P et al (2012) Safety and diagnostic yield of renal biopsy in the intensive care unit. Intens Care Med 38:1826\u20131833. https:\/\/doi.org\/10.1007\/s00134-012-2634-9","journal-title":"Intens Care Med"},{"key":"7266_CR88","doi-asserted-by":"publisher","unstructured":"Derebail VK (2021) Should PLEX be used for severe AKI and\/or pulmonary hemorrhage in ANCA-associated vasculitis (AAV)? PRO. Kidney 360 2:776\u2013778. https:\/\/doi.org\/10.34067\/KID.0006762020","DOI":"10.34067\/KID.0006762020"},{"key":"7266_CR89","doi-asserted-by":"publisher","unstructured":"Glassock RJ (2021) Should PLEX be used for severe AKI and\/or pulmonary hemorrhage in ANCA-associated vasculitis (AAV)? CON. Kidney 360 2:779\u2013781. https:\/\/doi.org\/10.34067\/KID.0004102020","DOI":"10.34067\/KID.0004102020"},{"key":"7266_CR90","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S (2019) Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med 381:291\u2013293. https:\/\/doi.org\/10.1056\/NEJMc1900045","journal-title":"N Engl J Med"},{"key":"7266_CR91","doi-asserted-by":"publisher","first-page":"33226","DOI":"10.1038\/srep33226","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Guo L, Chen Z et al (2016) Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. Sci Rep 6:33226. https:\/\/doi.org\/10.1038\/srep33226","journal-title":"Sci Rep"},{"key":"7266_CR92","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jca.21824","volume":"35","author":"A Yamagata","year":"2020","unstructured":"Yamagata A, Arita M, Tanaka A et al (2020) Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia. J Clin Apheresis 35:435\u2013443. https:\/\/doi.org\/10.1002\/jca.21824","journal-title":"J Clin Apheresis"},{"key":"7266_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13023-018-0931-2","volume":"13","author":"S Day","year":"2018","unstructured":"Day S, Jonker AH, Lau LPL et al (2018) Recommendations for the design of small population clinical trials. Orphanet J Rare Dis 13:195. https:\/\/doi.org\/10.1186\/s13023-018-0931-2","journal-title":"Orphanet J Rare Dis"},{"key":"7266_CR94","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","volume":"51","author":"LH Morrison","year":"2004","unstructured":"Morrison LH (2004) Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J Am Acad Dermatol 51:817\u2013819. https:\/\/doi.org\/10.1016\/j.jaad.2004.06.007","journal-title":"J Am Acad Dermatol"},{"key":"7266_CR95","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11259","volume":"92","author":"J Rey","year":"2007","unstructured":"Rey J, Belmecheri N, Bouayed N et al (2007) JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab. Haematologica 92:e101. https:\/\/doi.org\/10.3324\/haematol.11259","journal-title":"Haematologica"},{"key":"7266_CR96","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2020030348","volume":"31","author":"M Willicombe","year":"2020","unstructured":"Willicombe M, Thomas D, McAdoo S (2020) COVID-19 and Calcineurin inhibitors: should they get left out in the storm? J Am Soc Nephrol JASN 31:1145\u20131146. https:\/\/doi.org\/10.1681\/ASN.2020030348","journal-title":"J Am Soc Nephrol JASN"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-07266-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T18:03:26Z","timestamp":1706205806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-07266-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["7266"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-07266-7","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GD has no conflict of interest to disclose. YA has no conflict of interest to disclose. RB has received honararium from the Difficulty Airway Course. OR has no conflict of interest to disclose. MD reports having received consulting fees from Gilead-Kite, research support from MSD, and speaker fees from MSD, Gilead-Kite and Astellas. JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France, Sanofi Aventis France, Inotrem, MSD and Shionogi, all unrelated to this work and paid to her institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}